SKK 60060

Also Known As:

2-(tetradecyl)hexadecyl-O-(3-O-sulfo-alpha-L-fucopyranosyl)-(1-2)-3-O-sulfo-beta-D-galactopyranoside disodium salt; SKK-60060; SKK60060

Networked: 2 relevant articles (2 outcomes, 0 trials/studies)

1.	Uveitis 04/01/2003 - "The current findings suggest that SKK-60060 may be useful in the management of uveitis." 04/01/2003 - "Suppressive effects of selectin inhibitor SKK-60060 on the leucocyte infiltration during endotoxin induced uveitis."
2.	Ischemia 09/01/2000 - "Histological examination demonstrated protective effects of SKK-60060 on ischemia-induced retinal damage, which were more substantial in the inner retina (P < 0.01).SKK-60060 significantly inhibits the leukocyte rolling along the major retinal veins and their accumulation during the reperfusion period. "
3.	Reperfusion Injury 09/01/2000 - "These results suggest therapeutic potential of SKK-60060 for ischemia-reperfusion injury."